Comparing Intra-Arterial Chemotherapy Combined With Intravesical Chemotherapy Versus Intravesical Chemotherapy Alone: A Randomised Prospective Pilot Study for T1G3 Bladder Transitional Cell Carcinoma After Bladder-Preserving Surgery

被引:0
作者
Junxing Chen
Zhijun Yao
Shaopeng Qiu
Lingwu Chen
Yu Wang
Jianyong Yang
Jiaping Li
机构
[1] First Affiliated Hospital of Sun Yat-Sen University,Department of Urology
[2] First Affiliated Hospital of Sun Yat-Sen University,Department of Interventional Oncology
来源
CardioVascular and Interventional Radiology | 2013年 / 36卷
关键词
Bladder tumour; T1G3; Intra-arterial perfusion; Chemotherapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1521 / 1526
页数:5
相关论文
共 95 条
[1]  
Pham HT(1997)High-risk superficial bladder cancer: intravesical therapy for T1, G3 transitional cell carcinoma of the urinary bladder Semin Urol Oncol 15 147-153
[2]  
Soloway MS(1987)Stage T1, grade 3 transitional cell carcinoma of the bladder: an unfavorable tumor? J Urol 137 39-43
[3]  
Jakse G(2008)Early versus deferred cystectomy for initial high-risk pT1G3 urothelial carcinoma of the bladder: do risk factors define feasibility of bladder-sparing approach? Eur Urol 53 146-152
[4]  
Loidl W(2011)T1G3 high-risk NMIBC (non-muscle invasive bladder cancer): conservative treatment versus immediate cystectomy J Int Urol Nephrol 43 1047-1057
[5]  
Seeber G(2005)Optimal management of the T1G3 bladder cancer Urol Clin N Am 32 133-145
[6]  
Denzinger S(2007)Optimal management of high-risk T1G3 bladder cancer: a decision analysis PLOS Med 4 1538-1549
[7]  
Fritsche H-M(2006)Radiochemotherapy after transurethral resection for high-risk T1bladder cancer: an alternative to intravesical therapy or early cystectomy? J Clin Oncol 24 2318-2324
[8]  
Otto W(2007)A randomized trial of radical radiotherapy for the management of pT1G3 NXM0 transitional cell carcinoma of the bladder J Urol 178 807-813
[9]  
De Beradinis E(1996)A combined analysis of European Organization for Research and Treatment of Cancer, and Medical Research Council randomized clinical trials for the prophylactic treatment of TaT1 bladder cancer. European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative group and the Medical Research Council Working Part on Superficial Bladder Cancer J Urol 56 1934-1941
[10]  
Busetto GM(2010)An updated critical analysis of treatment strategy for newly diagnosed high-grade T1 (previously T1G3) bladder cancer J Eur Urol 57 60-70